HemaSphere Journal (IF = 12.1)
@Hemasphere_EHA
Followers
4,597
Following
605
Media
874
Statuses
1,869
Official #OpenAccess journal of #EHA , publishing highly relevant basic, translational, & clinical heme research. 2023 Impact Factor = 12.1
The Netherlands
Joined May 2020
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Arlington
• 351271 Tweets
Tulsi
• 280028 Tweets
#WWERaw
• 75638 Tweets
Martínez
• 47058 Tweets
Zuck
• 37778 Tweets
Romero
• 30149 Tweets
Gemini New Single 1M
• 28438 Tweets
O Vasco
• 28208 Tweets
#FranColapintoaF1
• 25579 Tweets
Vegetti
• 21086 Tweets
Q30 U STEAL MY HEART
• 20643 Tweets
Capitán
• 19845 Tweets
Giménez
• 13396 Tweets
BOSSNOEUL TBNW Q4
• 12887 Tweets
Guarello
• 12680 Tweets
Aguirre
• 10310 Tweets
スコルジャ
• 10170 Tweets
HemaSphere's April issue is now online. Please enjoy reading and sharing (all
#OpenAccess
) with your networks
👉
@EHA_Hematology
#hematology
20
47
338
HemaTopics are HemaSphere pubs focusing on hot heme topics. Today we focus on the latest HemaTopic by Sci Ed F Vinchi discussing advances in gene therapies for pts w/ hematologic diseases, such as β-Thalassemia, sickle cell disease & hemoglobinopathies.👉
11
31
262
Infection has emerged as a chief cause of NRM post CAR-T therapy. In this study authors explore severe & life-threatening inf. post licensed CAR-T therapy in large B-cell lymphoma. Authors examine pts who experienced ≥2 infections & those at ⬆️ risk👉
8
33
248
In this first ever report on hereditary spherocytosis (HS) mutational spectrum in Central Europe, authors analyzed 69 pts w HS in Austria. The findings emphasize combining family, lab, clinical, & NGS analyses for accurate HS patient characterization👉
3
19
230
🎉Our first 2024 issue is finally online, with more papers coming next week!
We're proud to now publish with Wiley, offering easy submission, transformative agreements (many authors will incur zero APCs!), + much more. Lots of good changes, all while we
9
16
203
HemaSphere's March issue is now online. Please enjoy reading and sharing (all
#OpenAccess
) with your networks👉
@EHA_Hematology
#hematology
9
7
170
✏️What skills are most important when serving as a manuscript peer reviewer? Our editors weigh in 👉 .
This is the final topic of the 2nd season of HemaSphere’s ‘Meet the Editors’ series, offering short, casual anecdotes from our experts. We hope you have
7
12
139
💡HemaSphere's June issue is open & hosts excellent content to read and share. As well, more publications will be added ahead ongoing. Have a browse through what's new 👉.
#hematology
#HemeTwitter
#MedTwitter
6
13
118
We're incredibly proud to report our first
#ImpactFactor
of 8.3 - a significant milestone! Celebrations abound; thank you for your readership 🙌.
#HemaSphere
remains committed to publishing high-quality, novel
#hematology
#research
that is
#openaccess
.
📚:
0
20
112
📣HemaSphere's October issue is now available. Please enjoy reading & sharing our 100%
#OpenAccess
publications with your networks 👉
#anemia
#hematopoiesis
#LymphoidMalignancies
#MyeloidMalignancies
#MachineLearning
#CART
#lymsm
#leusm
#lymphoma
0
10
96
🏆 Each month HemaSphere Chief Editor Prof Jan Cools selects Editor Highlights, which he calls out as new, must-read papers. We invite you to read, download, share, and cite this month’s Editor’s Highlight pick 👉
1
9
89
📖HemaSphere's June issue is complete. Please enjoy reading and sharing (all
#OpenAccess
) with your networks👉
#hematology
#HemeTwitter
#lymsm
#SCD
#MantleCellLymphoma
#UKALL60
+
#leusm
#ETO2
4
11
89
🏆Editor Pick: What are the crucial elements affecting final MFC-MRD read-outs for pts with
#AML
? Experts detail the potential + value of a harmonized, practical MFC-MRD assessment 👉
#HemaSphereHighlights
#FlowCytometry
#leusm
#MRD
2
13
96
📣HemaSphere's February 2023 issue is now online. Please enjoy reading & sharing (all
#OpenAccess
) with your networks 👉.
#vonWillebrand
#MouseModel
#hematopoiesis
#FollicularLymphoma
#MMsm
#lymsm
#CLLsm
#LymphoidMalignancies
#VEXASsyndrome
#ALLsm
2
15
76
HemaSphere's May issue is now complete and online. Please enjoy reading and sharing (all
#OpenAccess
) with your networks👉
@EHA_Hematology
#hematology
8
10
71
🎉Exciting news: our 2023 impact factor is 12.1! We are thankful for our editors, authors, reviewers, & readership. While this is 1 journal metric of many, it's an important milestone. We remain committed to high quality science + service. Browse our
#OpenAccess
content:
2
21
81
📣New:
#EHA
-
#ESMO
clinical practice guideline on primary CNS
#lymphomas
. We're thrilled to launch this collaborative publication that focuses on clinical, imaging, & pathological dx; staging & risk assessment; tx; & 1L and salvage tx algorithms 👉
5
18
64
🏆Editor Pick: Our Editor in Chief, Prof Jan Cools, calls out new, must-read papers monthly. Read, share, & cite this month’s pick: The MLL–Menin Interaction Is a Therapeutic Vulnerability in NUP98-rearranged AML, by M Rasouli et al 👉
#HemaSphereHighlights
0
4
64
The hematology community has lost a leading scientist who made important contributions to leukemia research, and who we all loved as a wonderful collaborator and friend. Thank you, Pieter Van Vlierberghe, for your support to EHA and HemaSphere.
1
13
67
We are thrilled to launch the EHA-ESMO joint publication on
#ClinicalPracticeGuidelines
for
#MultipleMyeloma
. Multidisciplinary European experts provide key treatment guidance, recommendations for myeloma complications, & more. Read here👉
#OpenAccess
#mmsm
0
17
58
🏆HemaSphere Chief Ed Prof Jan Cools selects Editor Highlights, calling out new, must-read papers. March 📰 Concomitant inhibition of the thioredoxin system & nonhomologous DNA repair potently sensitizes Ph+ lymphoid leukemia to tyrosine kinase inhibitors👉
3
8
59
📣HemaSphere's January 2023 issue is now online. Please enjoy reading & sharing (all open access) with your networks 👉.
#EHAReCon22
#CLL
#Neutropenia
#GeneTherapy
#ClonalHematopoiesis
#myelofibrosis
#LymphoidMalignancies
#CART
#MyeloidMalignancies
1
8
53
The 2021 impact factors are now final (June was a prelim release) so we had a cozy (🇳🇱gezellig) celebration with our colleagues. A warm thank you to
#EHA
for its support over the years 😍. Now back to publishing - Oct issue out soon.
#teamwork
#thanks
#ImpactFactor
#HemeTwitter
1
6
54
🤔If you could choose to witness any scientific breakthrough, what would it be? See what some of our editors say 👉
This is topic 2 of the 2nd season of HemaSphere’s ‘Meet the Editors’ series, offering short, casual anecdotes from our experts. Get to know
31
0
47
Breaking news from our Chief Editor: HemaSphere has earned an
#ImpactFactor
of 8.3 !
We are *delighted*. Deepest thanks to
@EHA_Hematology
and to HemaSphere's editors, authors, reviewers, & readership.
I am extremely happy to share the great news: The first impact factor of
@Hemasphere_EHA
, the journal of
@EHA_Hematology
is 8.3 - but above all,
#HemaSphere
is a strong
#Hematology
#Journal
supporting
#research
with full
#openaccess
and low publication fees!
14
26
251
3
7
49
🔀Have you ever received a piece of advice that has remained applicable no matter how life has twisted + turned? Hear our editors reflect upon the most lasting advice received during their aspiring scientist + researcher years 👉
This is topic 4 of the 2nd
1
5
40
💡What are the most exciting research topics our journal editors have come across recently? Have a look/listen👉
This is topic 1 of the 2nd season of HemaSphere’s
#MeetTheEditors
series, offering short, casual anecdotes from our experts. Get to know our
2
6
39
#GeneTherapy
&
#Hemophilia
- what's next so that widespread application of this treatment paradigm can be enabled? Read this recent, comprehensive review: the current state of hemophilia gene therapy and outlook on licensing a gene therapy product
👉
0
9
39
Each month HemaSphere Chief Editor Prof Jan Cools selects Editor Highlights, calling out new, must-read papers. Read, share & cite this month’s Highlight: Single cell analysis of MYD88 L265P and MYD88 WT Waldenström macroglobulinemia patients👉
#WM
2
7
36
🥁The
#HemaSpherePodcast
is live, with episode 1 on our website + all major podcast platforms (Spotify, Apple Podcast, etc). Listen + enjoy casual, insightful discussions about
#hematology
research. 🎧What to do next for "long COVID-19" of researchers? 👉
1
11
38
The more we share, the more we learn 🤝.
#HemaSphere
publications are free to view, download, & share. Have a browse - we welcome your engagement!
💻:
#HemeTwitter
#MedTwitter
#OpenAccess
#hematology
@EHA_Hematology
1
4
29
Such a pleasure to meet the winners of the HemaSphere 2024 awards, recognizing the importance of their studies for the heme field & for supporting to HemaSphere. Congrats to Marc Raaijmakers et al for their excellent study on
#azacytidine
treatment for
#VEXAS
syndrome.
📖:
1
6
32
HemaTopics are HemaSphere pubs focusing on🔥heme topics. This week we focus on the latest HemaTopic by Sci Editor F Vinchi: Luspatercept: A peaceful revolution in the standard of care for myelodysplastic neoplasms👉
@IronResearchLab
2
3
25
It is an honor to meet the winners of the HemaSphere 2024 awards, recognizing the importance of their studies for the heme field & for supporting to HemaSphere. Congrats to Mariana Bastos-Oreiro et al for their study on risk factors & mortality of COVID-19 in pts with
#lymphoma
.
2
9
31
Authors generated a single-cell expression atlas of 119,000
#AML
cells &
#stemcells
in paired dx-relapse samples & ID role of HIF pathway in drug res, demonstrating chem inhibition of HIF cooperates w/ SOC chemo to impair AML growth & elim AML stem cells👉
3
9
24
📢The Educational Updates in Hematology Book is published! Hosting insightful summaries from
#EHA25Virtual
Educational Sessions, this official
#HemaSphere
supplement highlights developments in
#basic
,
#translational
, &
#clinical
#research
.
Direct download
2
15
31
📣HemaSphere's March issue is now online. Please enjoy reading & sharing (all
#OpenAccess
) with your networks 👉.
#LiveSeq
#RedCells
#Iron
#SickleCellDisease
#MyeloidMalignancies
#hematopoiesis
#CLLsm
#MMsm
#LymphoidMalignancies
#CellTherapy
#lymsm
3
10
26
Real talk:
#BoneMarrowBiopsies
are not generally well tolerated. They cause
#ProceduralPain
, sometimes severe/persistent, for most ppl. Effective but underutilized interventions to⬇️pain exist, but how can we train practitioners about them? Read more 👉
1
5
27
Congratulations to David Kent, 2022 Janet Rowley Award recipient at
#ISEH2022
(& one of our amazing Scientific Eds!). A well-deserved recognition for his fantastic research accomplishments as well as his passion for advancing the work-life balance and recognition of scientists.
1
2
29
🏆 Editor highlight: Effects of fedratinib on patient-reported MF-related symptoms + HRQoL (Phase III
#JAKARTA
) for pts with no previous ruxolitinib. Explore the positive results & insightful discussion 👉
@mpdrc
@harrisoncn1
#HemaSphereHighlights
#mpnsm
1
5
25
News: HemaSphere's 2023 impact factor is 12.1. We are proud of and thankful for our editors, authors, reviewers, and readership!! 🎉
@EHA_Hematology
@WileyOnc_Hem
Happy to share that the 2023 journal impact factor of
@Hemasphere_EHA
is 12.1 !!!!! Although this is only one of the journal metrics, it is an important independent quality mark (Source: Clarivate, pending update of the JIF calculation).
@EHA_Hematology
#hematology
#OpenAccess
8
12
77
0
3
27
❓What helps you enjoy your commitments? Hear from some of our editors as to what is rewarding about being involved with HemaSphere 👉
This is topic 3 of the 2nd season of our ‘Meet the Editors’ series. Get to know our team + hear their insights about
0
3
24
How can we better understand/address
#sociodemographic
#inequities
in healthcare? Please read this thoughtful
#HemaTopics
“The Fragile Web of Care: Ethnicity, Poverty, and Language in Acute Leukaemia” 👉
#SocialDeterminantsOfHealth
0
4
24
📢The July
#HemaSphere
issue is now online. Please enjoy browsing & sharing our content, all of which is open access👉
#MyeloidMalignancies
#LymphoidMalignancies
#hematopoiesis
#lymsm
#leusm
#FollicularLymphoma
#MDS
#MMsm
#HSCs
#CART
#DLBCL
#GvHD
0
9
25
In this paper, authors assess the association between CHIP and COVID-19 severity in the Danish population using univariable and multivariable logistic regressions👉
0
4
22
Final chapter now online 🙌! Mapping urgent priorities in research & clinical science via the
#EHA
#ResearchRoadmap
: Malignant Lymphoid Diseases. Guiding the way to a more focused, funded European heme research future 👉
#MalignantLymphoma
#lymsm
0
9
23
🏆Editor highlight: Do you have an interest in
#myelofibrosis
? Dive into the use of
#fedratinib
and its impact on MF-related symptoms + overall
#HRQoL
as reported from the phase II JAKARTA2 Trial 👉
#HemaSphereHighlights
#mpnsm
0
8
21
What are the new, innovative treatments for
#RareAnemias
? Maria Domenica Cappellini et al discuss in this brand 🆕
#HemaSphere
article 👉 .
#OpenAccess
#EHA2021
#GeneEditing
#IronMetabolism
#SCD
#thalassemia
#CongenitalHemolyticAnemia
1
2
21
📣HemaSphere's June issue is online. With 25 publications, it's the largest issue to date! So proud of our authors & editors 🫶. Plus, 7 pubs are linked to
#EHA2023
talks. Enjoy reading & sharing 👉
#thrombosis
#hemophilia
#MMsm
#leusm
#CART
#GeneTherapy
1
7
23
Along with our high-quality publications, a lot of good things are happening at HemaSphere. We're immensely proud to confirm that HemaSphere's 2022 impact factor is 9.1 🎉. In addition, we're looking forward to the
#EHAReCon2024
program (abstract submissions due Friday!). Plus,
0
5
22
🎧The newest
#HemaSpherePodcast
episode is here! How can
#MachineLearning
be used for advanced heme-on disease prognostication + beyond? Authors of a recent HemaSphere publication discuss challenges + outcomes in utilizing a novel
#myelofibrosis
survival model that aids in risk
1
6
21
📣HemaSphere's August issue is now available. Please enjoy reading & sharing our 100%
#OpenAccess
publications with your networks 👉
#LymphoidMalignancies
#MyeloidMalignancies
#SickleCell
#VEXAS
#GeneTherapy
#histones
#lymsm
#leusm
0
5
21
📢The February
#HemaSphere
issue is now online, covering
#ALamyloidosis
#TransfusionMedicine
#GeneTherapy
#HemophiliaA
,
#LymphoidMalignancies
,
#MyeloidMalignancies
, & much more.
Enjoy browsing👉👈
0
2
19
📢The April
#HemaSphere
issue is now online. Enjoy browsing - all content is
#OpenAccess
👉
#FACS
#PatientExperience
#biologics
#CLL
#DLBCL
#BCellALL
#alloHCT
#hemophilia
#lymsm
#leusm
#GeneTherapy
#thrombosis
#hemostasis
1
9
17
📢The January
#HemaSphere
issue is now online, with a new look for the new year. This month we cover
#StemCells
,
#AML
,
#LymphoidMalignancies
,
#MyeloidMalignancies
,
#Thrombosis
, COVID-19,
#IronHomeostasis
, & more. Enjoy browsing! 👉
1
8
19
The Abstract Book for the
#EHA25Virtual
Congress contains exciting and ground-breaking research in all areas of
#hematology
. It is an official
#HemaSphere
supplement and available online ➡️
👏Congratulations to all of the authors & contributors!
1
12
19
Final analysis of the Phase III GALLIUM trial demonstrates long-term benefits of obinutuzumab-based immunochemotherapy, confirming its role as a standard of care for 1st-line treatment of pts with follicular lymphoma. 👉
#lymphoma
0
7
19
🎉The
#HemaSphere
June issue is now online 🎉
Browse our exciting new hematology publications linked to the
#EHA2021
scientific program 👉
As a reminder, our content is always
#OpenAccess
. Feel free to share widely.
1
7
17
Greetings from the EHA Research Conference in Bulgaria ⛄️ where the group is discussing molecular vulnerabilities in
#metabolism
& heme disorders. It's a closed meeting so we can't post content, but we look forward to meeting those of you here on the mountain. To those at home,
0
7
18
To honor today, World Leukemia Day, we have highlighted a selection of related HemaSphere publications. All are
#OpenAccess
. Read this new
#HemaBites
blog for featured
#leukemia
articles 👉
#WorldLeukemiaDay
#WLD21
#leusm
0
5
18
📢The May
#HemaSphere
issue is now online. Enjoy browsing our fully
#OpenAccess
content👉
#HSCs
#BTKinhibitors
#PCNA
#MCL
#cytokines
#PolycythemiaVera
#MyeloidMalignancies
#LymphoidMalignancies
#alloHCT
#AML
#lymsm
#leusm
0
6
17
Looking for exciting new
#hematology
publications? Today is your day🙌Visit our Latest Articles page & read 6 articles *just* posted👉
#MM
#mmsm
#HemophiliaA
#AcuteErythroleukemia
#ImmuneResistance
#BMmicroenvironment
#FollicularLymphoma
#IVDR
#HemaPolicy
0
2
16
Are you looking for novel, high-quality publications about basic, translational, & clinical
#hematology
?
#HemaSphere
,
#EHA
's peer-reviewed journal (2021 IF 8.3) can help. Browse our 6+ yrs (more to come!) of excellent content, all open access 👉 🩸🧬🔬
0
7
15
Today is
#WorldLeukemiaDay
. To increase awareness & provide education, here we offer a few related 2020 HemaSphere publications 👇
#AML
:
#CLL
:
PV to
#CMML
:
#WLD20
#BloodCancerAwarenessMonth
0
9
16
🌴Summer reading list: have you noticed our tweets starting with '🏆 Editor's Pick'? Our Editor in Chief highlights exciting, key articles monthly. We compiled all Editor highlights for the first half of 2023 - have a look:
Q1:
Q2:
0
3
17
🏆Editor Pick: How can we treat pts with cancer and acute or previous
#atherothrombotic
or
#thromboembolic
events? Read the new
#EHA
guidelines, in collaboration with ESC 👉
#antithrombosis
#anticoagulation
#HemaSphereHighlights
@EHA_Hematology
@escardio
0
9
17
"The danger for ill people is that they are taught how to be ill by professionals" (Arthur Frank). Patients + clinicians make sense of illness through stories. How can we frame these stories & illuminate our interactions? 👉
#HemaTopics
#MedicalHumanities
0
6
15
🏆Editor Pick: Can we predict individual effects of switching from standard to extended half-life products in people with
#hemophilia
? Explore study results + access predictive tables 👉
#HemaSphereHighlights
#pharmakokinetics
0
3
13
For those of you at
#EHAReCon22
, the poster session yesterday was 🔥! To allow for more space & less voice strain, today we've moved half of the posters outside (other half = same place as yesterday).
#ScienceWithAView
#KeepUpTheGreatTalks
0
1
17
June brings new impact factors, journal rankings, and also lots of additional exciting developments! Here are 3 things we're excited about right now. Read our
#OpenAccess
content at .
0
4
17
#Carfilzomib
is a proteasome inhibitor used for R/R
#MultipleMyeloma
, but the mechanism of
#RenalInjury
in related cardiorenal AEs is unknown. Authors propose
#eplerenone
as a novel prophylactic intervention 👉
#MMsm
#MineralocorticoidReceptor
0
4
16
🏆 Editor Pick: Understanding metabolic requirements of healthy
#HSCs
is critical to development of new therapies for heme disorders. Read about this eloquently presented, complex topic 👉
#mitochondria
#CellularMetabolism
#quiescence
#HemaSphereHighlights
2
6
16
It is an honor to meet the winners of the HemaSphere 2024 awards, recognizing the importance of their studies for the heme field & for supporting to HemaSphere. Congrats to Hélène Lapillonne et al for their study on molecular profiling in childhood
#AML
. Coauthor C Preudhomme
0
3
16
📢Exciting news:
#HemaSphere
will receive an impact factor in June 2022! This is an important milestone, and we're so thankful🤝to all of you - our authors, reviewers, editorial board, ambassadors, & readership. Cheers to the positive ☀️road ahead.
@EHA_Hematology
#OpenAccess
0
2
15
Let's celebrate HemaSphere co-editor in chief, Andreas Engert, as he rotates off from his leadership role at HemaSphere today. What a journey it has been! We wish him all the best ahead, & we would like to share some of his accomplishments at the journal to date. Herewith, a 🧵:
1
2
16
Syed Milan takes the floor to address audience questions after his excellent
#EHAReCon22
presentation on dysregulated ligand receptors in myelodysplasia.
#MDSsm
#MesenchymalStemCells
1
2
16
Authors show correlation between mechanical properties of B lymph cells & actomyosin cortex organization. Ibrutinib restores the physiological mechanical properties of CLL cells until onset of resistance. 👉
0
5
16
📣HemaSphere's May issue is now online. Please enjoy reading & sharing (all
#OpenAccess
) with your networks 📷
#MMsm
#IronMetabolism
#telomore
#MyeloidMalignancies
#FollicularLymphoma
#CART
#ICAHT
#leusm
#lymsm
#LymphoidMalignancies
#MPNsm
0
4
15
🏆Editor Pick: "A better understanding of the molecular mechanisms behind in vivo
#HSC
fate/identity acquisition within the dynamic cell hierarchies in the embryo is [sic] of vital importance..." 👉
@DrChrisSVink
@EdinUni_MeetCIR
#HemaSphereHighlights
0
2
16
📣The November
#HemaSphere
issue is now online. Please enjoy reading & sharing with your networks. 100% open access 👉
#BetaThalassemia
#POEMSsyndrome
#MDSsm
#LymphoidMalignancies
#HSCT
#lymsm
#AMLsm
#MPNsm
#BoneMarrow
#hematopoiesis
#MMsm
#leusm
0
7
16
Are you interested in cutting edge, peer-reviewed
#hematology
#publications
? We invite you to browse
#HemaSphere
, the official journal of the European Hematology Association. Our content is always
#OpenAccess
👉
@EHA_Hematology
1
3
15
#CART
,
#GeneTherapy
,
#HemeMalignancies
, heme disorders, heme
#policy
…and so much more! Have a browse around
#HemaSphere
,
@EHA_Hematology
's official
#PeerReviewed
journal
👉
We are indexed in
#PubMed
and 100%
#OpenAccess
0
6
14
💡Dawn Swan et al review
#cyclophosphamide
treatment for
#MultipleMyeloma
: its effect on the immune system & how it can be used synergistically with other treatment modalities such as
#IMiDs
,
#mAbs
, and cellular therapies. Read the full article 👉
0
9
15
Emmanuelle Passegue steps into the sunshine of the first scientific session, discussing deregulated
#HSC
behavior.
#EHAReCon22
0
1
15
🏆Editor Pick: Systemic manifestations from
#POEMSsyndrome
are commonly overlooked, diagnosis delayed, & consensus tx guidelines don't exist. Authors provide a clinical blueprint to manage POEMS + ⬆️ patient outcomes. Excellent review👉
#HemaSphereHighlight
1
5
14
🏆Editor Pick: Authors analyzed CNAs (
#CopyNumberAlterations
) in 493 pediatric pts with B-ALL being treated under the ICiCLe protocol. Read why they advocate for routine CNA testing + screening, and CNA risk status in future trials 👉
#HemaSphereHighlights
0
1
13
What is the optimum management of
#ChronicMyeloidLeukemia
? Maturing academic & commercial
#clinicaltrials
data are providing insights into the
#CML
landscape. Read this comprehensive review ➡️ .
#WCMLDay21
#AccessIsNeeded
0
8
14
💡Have you read the new guidelines on management of transfusion-dependent
#thalassemia
? We present here a detailed executive summary, thanks to
@thalassaemiaTIF
& an international panel of experts 👉
@FarmakisD
@AliTaherMD
#hematology
#thalassaemia
0
4
13
🏆Editor Pick: Large internat'l collab on transplant in
#myelofibrosis
from
@NicoGagelmann
et al shows that higher intensity conditioning does not lead to improved outcomes in higher risk disease in the molecular era 👉
#MPNsm
#BMTsm
#HemaSphereHighlights
2
2
13
Today is
#WorldCMLDay
. Focusing on education + awareness, we present 2 recent
#HemaSphere
articles for reading & sharing:
*Clinical benefit of Tx 👉
*Germ-line TP53 mut in
#CMML
/
#aCML
👉
#WCMLDay20
#BloodCancerAwarenessMonth
1
5
14
Interested in basic & translational
#research
? Register for the 4th
#YoungEHA
Research Meeting, this year online on June 11th. More info ⬇️
Want to expand your knowledge on basic & translational research in
#hematology
? Register now for the 4th
#YoungEHA
Research Meeting (accessible free of charge, outside of the
#EHA25Virtual
Congress Platform). It's happening Jun 11 (Thurs), from 9.30am.
👉
0
16
26
0
5
14
📢Newly published! A detailed review of COVID-19
#convalescentplasma
trials registered worldwide. Convalescent plasma seems to be safe, but potential risks such as
#TRALI
and
#AntibodyDependentEnhancement
are discussed.
#COVID19
#EHACOVID19
0
12
13
🏆Editor Pick: Genotyping is not routine at
#vonWillebrandDisease
diagnosis, but could it ⬆️ understanding of pathogenic mechanisms? Authors analyzed the VWF gene, setting the stage for future studies on gene variants 👉.
#HemaSphereHighlights
@WiN_Study_NL
0
4
13
Are you working on epidemiological data/research re: pts with hematologic malignancies &
#COVID19
? EPICOVIDEHA - an open, ready-to- use platform - can help. Read this new editorial 👉
@SalmantonGarcia
@CornelyOliver
@martinhoenigl
@ProfBMT
@KoehlerPh
0
10
13
To honor today, World MPN Day, we have highlighted a selection of related HemaSphere publications. All are
#OpenAccess
. Read this new
#HemaBites
blog for featured
#MPN
articles 👉
#MPNsm
#MPNvoice
#BloodCancer
0
10
13
We are incredibly happy to announce an enhancement to this year's
#EHA2023
congress - no charge childcare in Frankfurt. Well done,
@young_eha
team, for your work to get this on the docket and approved. 👏👏👏
@young_eha
's dream is coming true
#EHA2023
! Free of charge on-site childcare services for all registered participants. Check it out and 💡submit your abstract by March 01:
@EHA_Hematology
1
11
21
0
5
13